1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
6BCD76C27541C8B87852570A0004985BA
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/best-practices-pharmaceutical-budget-health-check!OpenDocument
18
19OpenDocument
2018.212.239.56
21
22
23www.best-in-class.com
24/bestp/domrep.nsf
25RC




Products & Services

Pharmaceutical Budget Health Check - Research & Consulting

ID: WP-28


Pages: 17


Published: Pre-2013


Delivery Format: Online


 

License Options:
close

Single User: Authorizes use by the person who places the order or for whom the order was placed.

Sitewide: Authorizes use of the report for a geographic site. All people at site can view the report for a year and copies can be printed.

Corporate: Authorizes use for the entire company for a year and copies can be printed. No limitations for usage inside the company.




Download White Paper

 

  • STUDY OVERVIEW
  • BENCHMARK CLASS
To ensure organizational health and competitiveness, companies must continually identify optimal resource levels for their operations. Sometimes, companies need to grow resources, while at other times, the need is to defend or shrink resources. Best Practices Pharmaceutical Budget Health Check allows pharmaceutical and biotech executives to assess the effectiveness of their organizational functions. Pharmaceutical and biotech companies planning their budgets can use Best Practices Budget Health Check to evaluate their resource and staffing allocations linked to specific business functions.

A complimentary sample of a customized Best Practices Pharmaceutical Budget Health Check is available to download by selecting the “Buy Now” link at the top right.

Content


The Best Practices Budget Health Check provides budget and staffing benchmark data for the following pharmaceutical and biotech business functions: Pharmaceutical and biotech executives and managers can compare their business functions to the industry as a whole, using the following key efficiency metrics:
    • FTE (Full Time Equivalent Resource) per Business Function
    • FTE Allocation by Activities Performed
    • Budget Allocation per Business Function
    • Budget Allocation per FTE
    • Budget Allocation Expressed as a Percentage of Sales and
    • Sales Per FTE

All benchmark data is presented in tables designed to allow viewers easy access. Findings are presented by business function and focus on 4 key efficiency metrics as per the table below:


More information about the content of the Health Check and examples of the analysis can be downloaded by selecting the “Buy Now” link at the top right.

Access


Best Practices Pharmaceutical Budget Health Check is now available for $20,500.00. The offer includes:
    • The comprehensive, 258-page Pharmaceutical Budget Health Check Benchmarking Guide for all 7 business functions listed above.
    • A customized data charting and data segmentation for 2 of the 7 business functions. The customized presentations involve taking client data and charting it against the current Health Check Benchmarks.
    • An analyst presentation and commentary for the customized business functions.
    • Additional business function customizations can be arranged.

Customized presentations take 5 - 10 working days to prepare.

A complimentary sample of a customized Best Practices Pharmaceutical Budget Health Check is available to download by selecting the “Buy Now” link at the top right.

About Best Practices, LLC

Best Practices, LLC is a research and consulting firm that works on the principle that organizations can chart a course to superior economic performance by studying the best business practices, operating tactics and winning strategies of world-class organizations. Our suite of customized Research and Consulting services is designed to assist you in improving your company's performance by analyzing the winning practices of leading corporations.


Industries Profiled:
Pharmaceutical; Biotech; Manufacturing; Consumer Products; Diagnostic; Medical Device; Chemical; Health Care; Academic


Companies Profiled:
Abbott Laboratories; Sanofi-aventis; Amgen; AstraZeneca; Bayer; Berlex; Bristol-Myers Squibb; Chiron; Elli Lilly; Genentech; GlaxoSmithKline; Johnson & Johnson; MedImmune; Merck; Novartis; Novo Nordisk; Pfizer; Proctor & Gamble; Roche; Solvay Pharmaceuticals; UCB Pharma